• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素II与心血管重塑的病理生理学

Angiotensin II and the pathophysiology of cardiovascular remodeling.

作者信息

Williams B

机构信息

Cardiovascular Research Institute, Leicester University Medical School, Leicester, UK.

出版信息

Am J Cardiol. 2001 Apr 19;87(8A):10C-17C. doi: 10.1016/s0002-9149(01)01507-7.

DOI:10.1016/s0002-9149(01)01507-7
PMID:11334763
Abstract

Hypertension is associated with a number of adverse morphologic and functional changes in the cardiovascular system. These include remodeling of the left ventricle, alterations in the morphology and mechanical properties of the vasculature, and the development of endothelial dysfunction. Recent studies have shown that angiotensin II is capable of mediating these changes via its interaction with the angiotensin II type 1 receptor. These nonhemodynamic effects of angiotensin II are independent of its effect on blood pressure. Thus, elevated levels of angiotensin II may lead directly to many hypertension-associated pathologies. Recent evidence that mechanical strain, oxidized low-density lipoprotein cholesterol, and aldosterone can cause upregulation of angiotensin II type 1 receptors indicates that activation of the renin-angiotensin system is not necessary for the actions of angiotensin II to be amplified. Because the strain on the vessel wall may be increased under conditions of hypertension, increased arterial pressure may amplify the actions of angiotensin II without a discernible increase in plasma angiotensin II levels. In both the myocardium and the peripheral vasculature, fibrosis is a major component of the remodeling that occurs in hypertension. There is substantial evidence that transforming growth factor beta-1 (TGF-beta(1)) mediates angiotensin-II-induced fibrosis in patients with hypertension and in those with a variety of nephropathies. Mechanical strain also induces fibrosis in a mechanism mediated by TGF-beta(1). This cytokine thus represents a common pathway by which angiotensin II and increased arterial pressure may induce cardiovascular fibrosis.

摘要

高血压与心血管系统的一些不良形态学和功能变化相关。这些变化包括左心室重塑、血管形态和力学特性改变以及内皮功能障碍的发生。最近的研究表明,血管紧张素II能够通过与1型血管紧张素II受体相互作用介导这些变化。血管紧张素II的这些非血流动力学效应独立于其对血压的影响。因此,血管紧张素II水平升高可能直接导致许多与高血压相关的病理状况。最近有证据表明,机械牵张、氧化型低密度脂蛋白胆固醇和醛固酮可导致1型血管紧张素II受体上调,这表明肾素-血管紧张素系统的激活对于血管紧张素II作用的放大并非必要。由于在高血压情况下血管壁上的牵张可能增加,动脉压升高可能会放大血管紧张素II的作用,而血浆血管紧张素II水平并无明显升高。在心肌和外周血管系统中,纤维化是高血压时发生的重塑的主要组成部分。有大量证据表明,转化生长因子β-1(TGF-β(1))介导高血压患者和各种肾病患者中血管紧张素II诱导的纤维化。机械牵张也通过TGF-β(1)介导的机制诱导纤维化。因此,这种细胞因子代表了血管紧张素II和动脉压升高可能诱导心血管纤维化的共同途径。

相似文献

1
Angiotensin II and the pathophysiology of cardiovascular remodeling.血管紧张素II与心血管重塑的病理生理学
Am J Cardiol. 2001 Apr 19;87(8A):10C-17C. doi: 10.1016/s0002-9149(01)01507-7.
2
The renin-angiotensin-aldosterone system: a specific target for hypertension management.肾素-血管紧张素-醛固酮系统:高血压管理的特定靶点。
Am J Hypertens. 1999 Dec;12(12 Pt 3):205S-213S. doi: 10.1016/s0895-7061(99)00103-x.
3
Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease.血管紧张素II是心血管疾病独立危险因素的实验和临床证据。
Am J Cardiol. 2001 Apr 19;87(8A):3C-9C. doi: 10.1016/s0002-9149(01)01538-7.
4
[The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].[血管紧张素II受体选择性阻断在心血管疾病治疗中的作用]
Clin Ter. 2001 Mar-Apr;152(2):103-6.
5
Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.肾素-血管紧张素-醛固酮系统在血管重塑和炎症中的作用:一项临床综述
J Hypertens. 2006 Jun;24(6):983-91. doi: 10.1097/01.hjh.0000226182.60321.69.
6
The role of the renin-angiotensin system in the development of cardiovascular disease.肾素-血管紧张素系统在心血管疾病发展中的作用。
Am J Cardiol. 2002 Jan 24;89(2A):3A-9A; discussion 10A. doi: 10.1016/s0002-9149(01)02321-9.
7
[Renin-angiotensin system and vascular remodelling].[肾素-血管紧张素系统与血管重塑]
Med Sci (Paris). 2004 Apr;20(4):409-13. doi: 10.1051/medsci/2004204409.
8
Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders.血管紧张素II在血压调节及心血管疾病病理生理学中的作用。
J Hum Hypertens. 1995 Nov;9 Suppl 5:S19-24.
9
Risk factor-induced cardiovascular remodeling and the effects of angiotensin-converting enzyme inhibitors.危险因素诱导的心血管重塑及血管紧张素转换酶抑制剂的作用
J Cardiovasc Pharmacol. 2008 Jun;51(6):523-31. doi: 10.1097/FJC.0b013e31817751a7.
10
[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].[血管紧张素转换酶抑制剂对慢性肾衰竭进展的影响]
Presse Med. 2002 Nov 9;31(36):1714-20.

引用本文的文献

1
Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention.心肌梗死后纤维化:病理生理学、检查与干预
Front Pharmacol. 2023 Mar 28;14:1070973. doi: 10.3389/fphar.2023.1070973. eCollection 2023.
2
Knockdown of CD146 promotes endothelial-to-mesenchymal transition via Wnt/β-catenin pathway.敲低 CD146 通过 Wnt/β-连环蛋白通路促进血管内皮细胞向间充质细胞转化。
PLoS One. 2022 Aug 24;17(8):e0273542. doi: 10.1371/journal.pone.0273542. eCollection 2022.
3
Left Ventricular Remodeling after Myocardial Infarction: From Physiopathology to Treatment.
心肌梗死后的左心室重构:从病理生理学到治疗
Life (Basel). 2022 Jul 24;12(8):1111. doi: 10.3390/life12081111.
4
Of Mouse and Man: Cross-Species Characterization of Hypertensive Cardiac Remodeling.鼠与人:高血压心脏重构的种间特征。
Int J Mol Sci. 2022 Jul 12;23(14):7709. doi: 10.3390/ijms23147709.
5
Stearoyl-CoA Desaturase (SCD) Induces Cardiac Dysfunction with Cardiac Lipid Overload and Angiotensin II AT1 Receptor Protein Up-Regulation.硬脂酰辅酶 A 去饱和酶 (SCD) 通过心脏脂质过载和血管紧张素 II AT1 受体蛋白上调诱导心脏功能障碍。
Int J Mol Sci. 2021 Sep 13;22(18):9883. doi: 10.3390/ijms22189883.
6
Increased AT receptor expression mediates vasoconstriction leading to hypertension in Snx1 mice.Snx1 小鼠中血管紧张素受体表达增加介导血管收缩导致高血压。
Hypertens Res. 2021 Aug;44(8):906-917. doi: 10.1038/s41440-021-00661-x. Epub 2021 May 10.
7
Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 through epigenetic modification.萝卜硫素通过表观遗传修饰激活 Nrf2 预防血管紧张素 II 诱导的心肌病。
J Cell Mol Med. 2021 May;25(9):4408-4419. doi: 10.1111/jcmm.16504. Epub 2021 Apr 1.
8
From ACE2 to COVID-19: A multiorgan endothelial disease.从血管紧张素转换酶2到2019冠状病毒病:一种多器官内皮疾病
Int J Infect Dis. 2020 Nov;100:425-430. doi: 10.1016/j.ijid.2020.08.083. Epub 2020 Sep 5.
9
Effects of Olive Oil on Blood Pressure: Epidemiological, Clinical, and Mechanistic Evidence.橄榄油对血压的影响:流行病学、临床和机制证据。
Nutrients. 2020 May 26;12(6):1548. doi: 10.3390/nu12061548.
10
Prorenin independently causes hypertension and renal and cardiac fibrosis in cyp1a1-prorenin transgenic rats.原啡淋独立引起 CYP1A1-原啡淋转基因大鼠的高血压和肾及心脏纤维化。
Clin Sci (Lond). 2018 Jun 28;132(12):1345-1363. doi: 10.1042/CS20171659. Print 2018 Jun 29.